KLC · KinderCare Learning Companies, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on KLC. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About KLC · KinderCare Learning Companies, Inc.
KinderCare Learning Companies, Inc. provides early childhood education and care services in the United States. The company offers community-based early childhood education services for infants, toddlers, preschool, and kindergarten students; and customized family care benefits for organizations, including care for young children on or near the site where their parents work, tuition benefits, and backup care under the KinderCare Learning Centers (KCLC) and Crème School brands. It also provides before-and after-school programs, including summer camp programs for preschool and school-age children under the Champions brand. The company was formerly known as KC Holdco, LLC and changed its name to KinderCare Learning Companies, Inc. in January 2022. KinderCare Learning Companies, Inc. was founded in 1969 and is headquartered in Lake Oswego, Oregon.
Live Quote
SELL (score -3) · 12-1 mom -62.7% · RSI 58.2 · above_50_only · -60.1% from high
Targets blend Wall Street consensus (7 analysts: low $2.50 / mean $4.24 / high $6.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
KLC is the largest US private provider of early childhood education (1,555+ KCLC centers, $2.74B revenue). The stock has collapsed ~64% from its October 2024 IPO price of $18 to ~$3.96 as enrollment softness triggered a guidance reset and goodwill impairment charges in FY2025/Q1 2026 ($273M Q1 write-off). CEO Tom Wyatt made substantial open-market purchases (494,118 shares at $1.96–$2.07 on March 16-18) totaling ~$970K — a significant insider signal near the stock's all-time low of $1.75. Three independent directors received RSU grants in June 2026 ($0 strike). However, fundamental deterioration is severe: Q1 net loss of $290M (impairment-driven), negative operating margins, elevated debt/leverage, and no clear catalyst for re-rating within the next 3-12 months beyond potential enrollment stabilization. BMO recently raised its price target to $6 with an Outperform rating.